Trial record 1 of 1 for: 0761-010
Previous Study | Return to List | Next Study
Study of KW-0761 Versus Vorinostat in Relapsed/Refractory CTCL
This study is ongoing, but not recruiting participants.
Kyowa Hakko Kirin Pharma, Inc.
Information provided by (Responsible Party):
Kyowa Kirin Pharmaceutical Development, Inc. ( Kyowa Hakko Kirin Pharma, Inc. )
First received: October 25, 2012
Last updated: April 26, 2017
Last verified: April 2017
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is ongoing, but not recruiting participants.|
|Estimated Study Completion Date:||December 2018|
|Primary Completion Date:||March 2017 (Final data collection date for primary outcome measure)|